Healthcare
AbbVie to Acquire Landos Biopharma: Advancing Novel Oral Therapies for Autoimmune Diseases
AbbVie's Acquisition of Landos Marks a Strategic Move in Autoimmune Disease Treatment Development AbbVie Inc. (ABBV) has announced a definitive...
Yield10 Hits Regulatory Milestone for Omega-3 Camelina
USDA's Approval Signals Advancement in Land-Based Production of Essential Fatty Acids Yield10 Bioscience (YTEN) has achieved a significant regulatory milestone,...
IGC Pharma’s IGC-AD1 Shows Promising Results in Alzheimer’s Agitation Trial
Interim Analysis Reveals Statistically Significant Reduction in Agitation Levels IGC Pharma (IGC) has unveiled encouraging findings from its ongoing Phase...
XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction
Expanding Portfolio Strengthens XTL's Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has...
BioNTech Reports Revenue Plunge as Focus Shifts to Cancer Drugs
Shares Fall Over 9% as Biotech Giant Transitions Away from Pandemic-Era Vaccine Sales BioNTech (BNTX), the pioneering biotechnology firm behind...
AstraZeneca to Acquire Fusion Pharmaceuticals: Pioneering Precision Cancer Treatments
Acquisition Marks AstraZeneca's Commitment to Advancing Cancer Care with Radioconjugates AstraZeneca, (AZN) a leading global biopharmaceutical company, has announced a...
FDA Delays Decision on Eli Lilly’s Alzheimer’s Drug, Donanemab
Eli Lilly's anticipation for the Food and Drug Administration's approval decision regarding its Alzheimer's treatment, donanemab, faces a setback as...
Vivani Medical Unveils Promising Preclinical Data on Weight Loss Implants
Vivani Medical (VANI) released preclinical data on weight loss effects for NPM-115 Vivani Medical (VANI) on Wednesday, unveiled preclinical findings...
Janux Therapeutics Unveils Promising Updates on Cancer Treatments
Janux Therapeutics Inc (JANX) disclosed updated findings on its experimental drugs, JANX007 and JANX008, showcasing significant progress in treating metastatic...
Ocular Therapeutix Announces Private Placement to Bolster Clinical Development Initiatives
Ocular Therapeutix, Inc. (OCUL), a pioneering biopharmaceutical company dedicated to advancing vision-related therapies, has disclosed its strategic move to enhance...
